Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Epigenetic and oncogenic inhibitors converge to drive a metabolic catastrophe in castration-resistant prostate cancer.

The Journal of clinical investigation·2026

Same author

Expert opinion on burning questions in cancer myeloid cell biology.

Journal for immunotherapy of cancer·2026

Same author

Taxane chemotherapy promotes response to TIM-3 checkpoint blockade via STING-mediated ER stress and HMGB1 secretion.

Cell reports. Medicine·2026

Same author

EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Proapoptotic Regulators.

Cancer research·2026

Same author

Protocol for specific induction of apoptosis or necroptosis in established murine tumors.

STAR protocols·2025

Same author

Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models.

Journal for immunotherapy of cancer·2025

Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026

Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026

Same journal

Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition.

Immunity·2026

Same journal

The transcription factor Eomes drives a stemness program in CD4<sup>+</sup> T cells that promotes anti-tumor immunity in response to immunotherapy.

Immunity·2026

Same journal

Stem-like precursors of exhausted Th cells upheld by a Tox-Myb-Eomes transcriptional hierarchy propagate Th cell responses in chronic infection.

Immunity·2026

Same journal

Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes.

Immunity·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 15, 2026

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

moDCs, Less Problems.

Alycia Gardner¹, Brian Ruffell²

¹Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Cancer Biology PhD Program, University of South Florida, Tampa, FL 33620, USA.

|January 19, 2018

Summary

This summary is machine-generated.

Type 1 conventional dendritic cells are crucial for anti-tumor immunity. A new study reveals a similar monocyte-derived population in tumors that enhances T cell responses during cancer therapy.

More Related Videos

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

Related Experiment Videos

Last Updated: Feb 15, 2026

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

Area of Science:

Immunology
Cancer Biology
Cellular Biology

Background:

Type 1 conventional dendritic cells (cDC1s) are essential for initiating anti-tumor immune responses.
The precise cellular mechanisms that support T cell activation within the tumor microenvironment during therapy remain incompletely understood.

Purpose of the Study:

To identify and characterize myeloid cell populations within inflamed tumors that contribute to anti-tumor immunity.
To investigate the role of these cells in promoting T cell responses during cancer therapy.

Main Methods:

Flow cytometry and single-cell RNA sequencing were used to analyze immune cell populations in tumor tissues.
In vivo and in vitro assays were performed to assess the functional capacity of identified cell populations in supporting T cell responses.

Main Results:

Sharma et al. identified a distinct monocyte-derived cell population exhibiting a phenotype similar to cDC1s within inflamed tumors.
This monocyte-derived population was found to be critical for enhancing T cell proliferation and effector function during anti-cancer therapy.

Conclusions:

Monocyte-derived cells can functionally compensate for or collaborate with cDC1s in promoting anti-tumor immunity.
Targeting these monocyte-derived cells represents a potential therapeutic strategy to augment anti-tumor immune responses.